Patricia Sanchez
Family · Huntington Park, CANPI 1649843400
Payments from drug & device makers
Across 198 payments — averaging $27.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$800
- Amgen$724
- Bayer$331
- Lilly USA, LLC$329
- GSK$320
- Dexcom, Inc.$304
- plus $3K from 30 others
What the payments were for
- Consulting fees$80014%
- Food & beverage$4,74086%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $800 |
| Amgen | 36 | $724 |
| Bayer | 10 | $331 |
| Lilly USA, LLC | 16 | $329 |
| GSK | 7 | $320 |
| Dexcom, Inc. | 12 | $304 |
| Mannkind Corporation | 17 | $298 |
| Merck | 9 | $264 |
| Johnson & Johnson | 9 | $230 |
| Boehringer Ingelheim | 6 | $225 |
| AbbVie | 9 | $214 |
| Novo Nordisk | 10 | $201 |
| Corcept Therapeutics | 6 | $171 |
| Edwards Lifesciences | 1 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $120 |
| Esperion Therapeutics, Inc. | 1 | $113 |
| Novartis | 5 | $101 |
| Tandem Diabetes Care, Inc. | 4 | $92 |
| AstraZeneca | 5 | $84 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Ionis Pharmaceuticals, Inc. | 1 | $33 |
| Shield Therapeutics Inc | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Pfizer | 1 | $31 |
| Rhythm Pharmaceuticals, Inc. | 1 | $29 |
| Cequr Corporation | 2 | $28 |
| Sequel Med Tech, LLC | 1 | $24 |
| Avanos Medical | 1 | $23 |
| Insulet Corporation | 1 | $23 |
| Abiomed | 1 | $23 |
| Theracosbio, LLC | 1 | $22 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- VERQUVO$230
- Kerendia$135
- AFREZZA$125
- SHINGRIX$125
- Repatha$124
- TRELEGY ELLIPTA$123
- Edwards SAPIEN 3 Transcatheter Heart Valve$122
- NEXLIZET$113
- NEXLETOL$113
- JARDIANCE$102
How this compares
$5,540 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 69 | $71,437 |
| OzempicSemaglutide | 61 | $63,802 |
| TrulicityDulaglutide | 42 | $41,741 |
| FarxigaDapagliflozin Propanediol | 50 | $41,510 |
| MounjaroTirzepatide | 23 | $22,569 |
| AfrezzaInsulin Regular, Human | 11 | $21,415 |
| Levothyroxine Sodium | 31 | $388 |
| Methimazole | 18 | $329 |
| Calcitriol | 11 | $318 |
| Rosuvastatin Calcium | 11 | $258 |
| Atorvastatin Calcium | 35 | $249 |
| Metformin Hcl | 48 | $247 |
| Pioglitazone Hcl | 14 | $162 |
| Glipizide ErGlipizide | 14 | $63 |
| Lisinopril | 23 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $225 | $71,43769 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $329 | $64,31165 claims |
| Novo NordiskOzempic | $201 | $63,80261 claims |
| AstraZenecaFarxiga | $84 | $41,51050 claims |
| Mannkind CorporationAfrezza | $298 | $21,41511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Huntington Park
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.